Arkansas
Little Rock; K&S Professional Research Services, LLC
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
California
Cerritos; Comprehensive NeuroScience Inc. Cerritos
Cerritos, CA - Schizophrenia
Costa Mesa; ATP Clinical Research
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Culver; California Clinical Trials Medical Group, Inc.
Do you have schizophrenia or schizoaffective disorder?
Glendale; Behavioral Research Specialists, LLC
Phase I, Bioequivalency for XXX, in subjects with Schizophrenia, Schizoaffective D/O or Bipolar D/O.
Glendale; CNS Healthcare
Schizophrenia and Schizoaffective Disorders Study
Glendale; California Clinical Trials Medical Group, Inc.
An inpatient study comparing different types of the same study medication administered to subjects with schisophrenia, schizoaffective disorder, or schisophreniform disorder.
Granada Hills; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Los Angeles; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Oceanside; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Orange; UC Irvine Medical Center
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Palo Alto; Stanford University School of Medicine
The study is looking at the metabolic side effects of the new antipsychotic medications. Participants should be stable on one of the following medications: olanzapine (zyprexa), ziprasidone (geodon), risperidone (risperdal) or aripiprazole (abilify). Patient's medications won't be changed. The study involves 3 visits at the Palo Alto VA and Stanford Hospital.
San Diego; CNRI - San Diego
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Stanford; Stanford University School of Medicine
Treatment of Schizoaffective Disorder Using Mifepristone
Stanford; Stanford University School of Medicine
First Episode Psychosis Study (CAFÉ)
Stanford; Stanford University School of Medicine
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Connecticut
New Britain; The Hospital of Central Connecticut
Do you take one of these medications for SCHIZOPHRENIA: Zyprexa, Risperdal, Risperdal Consta, Invega, Seroquel or Abilify?
Florida
Gainesville; University of Florida
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Maitland; Florida Clinical Research Center (formerly Core Research)
Diagnosed with Schizophrenia?
Orlando; CNS Healthcare - Orlando
Schizophrenia Research Study (and schizoaffective disorders)
Georgia
Atlanta; Comprehensive NeuroScience Inc. Atlanta
Atlanta, GA - Schizophrenia
Atlanta; Comprehensive NeuroScience Inc. Atlanta
Atlanta, GA - Insomnia
Illinois
Chicago; Uptown Research Institute, LLC
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Hoffman Estates; Alexian Brothers
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Hoffmann Estates; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Oakbrook Terrace; Midwest Center for Neurobehavioral Medicine
Clinical study for Schizophrenia
Kansas
Wichita; Clinical Research Institute - Kansas
Comparison of Antipsychotics for Metabolic Problems (CAMP) in the Treatment of People with Schizophrenia or Schizoaffective Disorder
Louisiana
Lake Charles; Lake Charles Clinical Trials
Switch Study of Existing Atypical Antipsychotics to Bifeprunox
Lake Charles; Lake Charles Clinical Trials
Study Comparing Bifeprunox to Risperidone in the Treatment of Outpatients with Schizophrenia with Weight as the Primary Endpoint
Lake Charles; Lake Charles Clinical Trials
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
Shreveport; J. Gary Booker, MD
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Shreveport; Psychopharmacology Research Clinic LSUHSC-Shreveport
CAMP Schizophrenia Study
Maryland
Baltimore; Sheppard Pratt Health System
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Massachusetts
Boston; Schizophrenia Program, Freedom Trail Clinic
High-Dose Oral Ziprasidone vs Conventional Dosing in Schizophrenia Patients with Residual Symptoms
Boston; Freedom Trail Clinic
Relapse Prevention: Long-acting Atypical Antipsychotics
Boston; MGH - Massachusetts General Hospital
MK-0777 for the Treatment of Cognitive Impairments for Patients with Schizophrenia
Boston; Beth Israel Deaconess
Safety and therapeutic efficacy of cerebellar repetitive transcranial magnetic stimulation in patients with schizophrenia
Boston; MGH - Massachusetts General Hospital
Effects of eszopiclone on Sleep and learning in chronic, medicated schizophrenia patients
Boston; MGH - Massachusetts General Hospital
Intranasal Insulin Treatment in Patients with Schizophrenia
Boston; MGH - Massachusetts General Hospital
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients with Schizophrenia
Boston; Boston University Psychiatry Associates
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Taunton; CCBC
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
New Jersey
Cherry Hill; Center For Emotional Fitness
Schizophrenia Can Decrease Your Memory and Your Thinking Ability
Clementon; CRI Worldwide
A randomized, double-blind, parallel-group, flexible-dose study exploring the neurocognitive effects of XXXX vs. XXXX in patients with schizophrenia using the MATRICS Consensus Cognitive Battery.
Clementon; CRI Worldwide
A Single-arm Evaluation of the Safety of XXXX Extended-Release (ER) in Subjects with Schizophrenia or Schizoaffective Disorder with Hepatic Disease.
Clementon; CRI Worldwide
An open label study to evaluate the effect of repeated administration of XXXX on the pharmacokinetics of XXXX following administration of the immediate release formulation of Tablets XXXX in patients with Schizophrenia.
Clementon; CRI Worldwide
A Phase IIa, Single-Blind, Placebo Controlled Trial to Evaluate the Pro-Cognitive Effects of XXXX in Patients with Schizophrenia.
Clementon; CRI Worldwide
A Single-arm Evaluation of the Safety of XXXX Extended-Release (ER) in Subjects with Schizophrenia or Schizoaffective Disorder with Hepatic Disease.
Clementon; CRI Worldwide
A long term safety, tolerability, and effectiveness of XXXX in subjects with Schizophrenia or Schizoaffective disorder: A randomized, active comparator-controlled study.
Clementon; CRI Worldwide
A phase 2a, multi-center randomized, double-blind parallel group, placebo-controlled study to evaluate the safety and efficacy of XXX as adjunctive treatment in combination with a preexisting antipsychotic in patients with cognitive impairments associated with schizophrenia.
Clementon; CRI Worldwide
A Single Dose, Open-Label, Randomized, 2-Period, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of XXXX 3-month formulation in Subjects with Schizophrenia.
Clementon; CRI Worldwide
An Open-Label, Long-Term, Multiple-Dose, Safety and Tolerability, Pharmacokinetic Study of XXXX in the Treatment of Subjects with Schizophrenia.
Clementon; CRI Worldwide
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
New York
Brooklyn; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Cedarhurst; Neurobehavioral Research, Inc.
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Elmsford; Advanced Bio-Behavioral Sciences
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Holliswood; Comprehensive NeuroScience Inc. Holliswood
Holliswood, NY - Schizophrenia
New York; Mount Sinai Medical Center
Molecular Genetics of Schizophrenia
New York; Weill Cornell Medical College
This is a study investigating an 8-week long trial of Acceptance and Commitment Therapy (ACT) for Delusions. ACT is similar to Cognitive Behavioral Therapy (CBT) which has been successfully used with patients with delusions.
New York; Social Psychiatry Research Institute
Are you suffering from Schizophrenia?
New York; Social Psychiatry Research Institute
Are you suffering from Schizophrenia?
New York; New York State Psychiatric Institute
Treatment of Negative Symptoms and Social Dysfunction of Schizophrenia with Transcranial Magnetic Stimulation (TMS)
New York; Mount Sinai Medical Center
White Matter Abnormalities in Schizophrenia
New York; Mount Sinai Medical Center
Comparison of Atypicals for First Episode (C.A.F.E)
New York; New York State Psychiatric Institute
Schizophrenia Research Studies
New York; Mount Sinai Medical Center
Clinical Antipsychotic Trials of Intervention Effectiveness (C.A.T.I.E)
Rochester; Strong Ties
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Staten Island; Richmond Behavioral Associates
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Staten Island; Behavioral Medical Research of Staten Island
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Ohio
Cincinnati; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Cleveland; Saroj Brar, MD, Inc.
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Dayton; Midwest Clinical Research Center
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
Oklahoma
Oklahoma City; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Pennsylvania
Norristown; Keystone Clinical Studies, LLC
OUT-PATIENT SCHIZOPHRENIA STUDY
Norristown; Keystone Clinical Studies, LLC
SCHIZOPHRENIA RESEARCH
Norristown; Keystone Clinical Studies, LLC
SCHIZOPHRENIA STUDY
Tennessee
Memphis; CNS Healthcare - Memphis
Schizophrenia Research Study (and Schizoaffective Disorder)
Texas
Austin; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
De Soto; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Houston; MedLabs Research of Houston, Inc.
Cognitive Deficits in Schizophrenia
Houston; MedLabs Research of Houston, Inc.
Patients Needed for Schizophrenia Research
Houston; MedLabs Research of Houston, Inc.
If you've been diagnosed with schizophrenia and have been stable for the past five months, that's very good news.
Houston; MedLabs Research of Houston, Inc.
Schizophrenia or Schizoaffective Disorder Clinical Research Study Now Enrolling
San Antonio; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Virginia
Richmond; Alliance Research Group
Alliance Research Group is conducting clinical trials in the following therapeutic areas:
Washington, DC
Washington; Comprehensive NeuroScience Inc. Washington DC
Washington, DC - Schizophrenia
International
Wien, Austria; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Curitiba, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Pelotas, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Rio De Janeiro, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Salvador, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Sao Paulo, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Săo Paulo, Brazil; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Marseille, France; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Orvault, France; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Toulon, France; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Achim, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Bochum, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Freiburg, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Hamburg, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Nürnberg, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Westerstede, Germany; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Balassagyarmat, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Budapest, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Gyor, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Nyíregyháza, Hungary; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Aichi, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Chiba, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Fukuoka, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Hiroshima, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Hokkaido, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Kanagawa, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Nagasaki, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Niigata, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Osaka, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Tokushima, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Tokyo, Japan; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Mexico City, Mexico; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Monterrey, Mexico; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Bydgoszcz, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Skorzewo, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Torun, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Tuszyn, Poland; Research Site:
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
